Stocktoria
Incannex Healthcare Inc. IXHL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-03-18
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $86,000 | $12,000 | — | — |
| Operating income | -$23.8M | -$30.0M | — | -$49.7M |
| Net income | -$46.9M | -$18.5M | — | -$48.8M |
| Operating cash flow | -$12.5M | -$15.8M | — | -$10.7M |
| Free cash flow | -$12.5M | -$16.1M | — | -$11.1M |
| Total assets | $20.4M | $17.0M | $22.4M | $23.8M |
| Total liabilities | $7.1M | $5.8M | $3.5M | $3.0M |
| Shareholders' equity | $13.4M | $11.2M | $18.9M | $20.8M |
| Ratios | ||||
| Operating margin | -27661.6% | -250341.7% | — | — |
| Net margin | -54517.4% | -153825.0% | — | — |
| FCF margin | -14559.3% | -134350.0% | — | — |
| Return on assets | -229.3% | -108.3% | — | -205.2% |
| Return on equity | -350.2% | -164.6% | — | -234.4% |
| Current ratio | 2.86 | 2.88 | 6.70 | 9.02 |
| Revenue growth | 616.7% | — | — | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001873875 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.